Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion type Assertion NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_head.
- NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion description "[We now report that our NSCLC MHC II vaccines prepared from adeno, squamous or large cell carcinomas each activate CD4(+) T cells that cross-react with the other NSCLC subtypes and do not react with HLA-DR-matched normal lung fibroblasts or other HLA-DR-matched nonlung tumor cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_provenance.
- NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion evidence source_evidence_literature NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_provenance.
- NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion SIO_000772 20473949 NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_provenance.
- NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion wasDerivedFrom befree-20140225 NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_provenance.
- NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_assertion wasGeneratedBy ECO_0000203 NP615223.RA8vMcaAoQfU0xOm9eg1dWAIdZJWZ9eMguFCHdt9h9okw130_provenance.